Literature DB >> 3356786

Agglutinins and antibodies to Francisella tularensis outer membrane antigens in the early diagnosis of disease during an outbreak of tularemia.

L Bevanger1, J A Maeland, A I Naess.   

Abstract

Tularemia was diagnosed in 57 patients during an outbreak in central Norway in 1984 and 1985. Clinical categories of the disease showed seasonal variations. A bacterial microagglutination test and an enzyme-linked immunosorbent assay (ELISA) with class-specific antibodies against Francisella tularensis outer membrane (OM) antigens were evaluated for the early diagnosis of tularemia. ELISA with immunoglobulin G (IgG), IgA, or IgM antibodies and the microagglutination test differed only marginally in diagnostic sensitivity. The OM preparation harbored F. tularensis agglutinogens and contained a variety of proteins, several of which functioned as immunogens in tularemia patients, as shown by Western blotting (immunoblotting). All 12 patients tested produced antibodies against a 43,000-molecular-weight OM protein. Individual variation was noted with regard to antibody response against other OM antigens. The OM is a suitable antigen preparation in ELISA for the diagnosis of tularemia and, presumably, contains antigens important in the immunobiology of tularemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3356786      PMCID: PMC266308          DOI: 10.1128/jcm.26.3.433-437.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Characterization of the major envelope protein from Escherichia coli. Regular arrangement on the peptidoglycan and unusual dodecyl sulfate binding.

Authors:  J P Rosenbusch
Journal:  J Biol Chem       Date:  1974-12-25       Impact factor: 5.157

2.  Human infections with Francisella tularensis in Norway. Development of a serological screening test.

Authors:  R H Haug; A D Pearson
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

3.  Airborne tularemia in Sweden.

Authors:  S Dahlstrand; O Ringertz; B Zetterberg
Journal:  Scand J Infect Dis       Date:  1971

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria.

Authors:  Y D Karkhanis; J Y Zeltner; J J Jackson; D J Carlo
Journal:  Anal Biochem       Date:  1978-04       Impact factor: 3.365

6.  Enzyme-linked immunosorbent assay for immunological diagnosis of human tularemia.

Authors:  H E Carlsson; A A Lindberg; G Lindberg; B Hederstedt; K A Karlsson; B O Agell
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

7.  Immunity against Francisella tularensis in northern Finland.

Authors:  P Koskela; E Herva
Journal:  Scand J Infect Dis       Date:  1982

8.  Sodium dodecyl sulfate-polyacrylamide gel typing system for characterization of Neisseria meningitidis isolates.

Authors:  L F Mocca; C E Frasch
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

9.  Evaluation of a safranin-O-stained antigen microagglutination test for francisella tularensis antibodies.

Authors:  S L Brown; F T McKinney; G C Klein; W L Jones
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

10.  Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis.

Authors:  G Sandström; A Tärnvik; H Wolf-Watz
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

View more
  29 in total

1.  Serosurveillance for Francisella tularensis among wild animals in Japan using a newly developed competitive enzyme-linked immunosorbent assay.

Authors:  Neekun Sharma; Akitoyo Hotta; Yoshie Yamamoto; Akihiko Uda; Osamu Fujita; Toshio Mizoguchi; Junji Shindo; Chun-Ho Park; Noboru Kudo; Hitoshi Hatai; Toshifumi Oyamada; Akio Yamada; Shigeru Morikawa; Kiyoshi Tanabayashi
Journal:  Vector Borne Zoonotic Dis       Date:  2014-04-01       Impact factor: 2.133

2.  Characterization of Francisella tularensis outer membrane proteins.

Authors:  Jason F Huntley; Patrick G Conley; Kayla E Hagman; Michael V Norgard
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

3.  Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis.

Authors:  D M Waag; K T McKee; G Sandstrom; L L Pratt; C R Bolt; M J England; G O Nelson; J C Williams
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

4.  Tularemia in Bursa, Turkey: 205 cases in ten years.

Authors:  S Helvaci; S Gedikoğlu; H Akalin; H B Oral
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

5.  Levels of interleukin 6 and tumor necrosis factor in serum from humans vaccinated with live, attenuated Francisella tularensis.

Authors:  T Krakauer
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

6.  Diagnostic approaches for oculoglandular tularemia: advantages of PCR.

Authors:  Todor Kantardjiev; Plamen Padeshki; Ivan N Ivanov
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

7.  Tularemia in children.

Authors:  Solmaz Celebi; Mustafa Hacimustafaoglu; Suna Gedikoglu
Journal:  Indian J Pediatr       Date:  2008-09-22       Impact factor: 1.967

Review 8.  [Lactobacillus spp. as part of the normal microflora and as pathogens in humans].

Authors:  E Shopova
Journal:  Akush Ginekol (Sofiia)       Date:  2001

9.  Water- and airborne Francisella tularensis biovar palaearctica isolated from human blood.

Authors:  T Hoel; O Scheel; S H Nordahl; T Sandvik
Journal:  Infection       Date:  1991 Sep-Oct       Impact factor: 3.553

10.  Cell-mediated and humoral immune responses induced by scarification vaccination of human volunteers with a new lot of the live vaccine strain of Francisella tularensis.

Authors:  D M Waag; A Galloway; G Sandstrom; C R Bolt; M J England; G O Nelson; J C Williams
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.